Locations
Philadelphia, PA, USA · United States
industry
Health · Biotechnology · DeepTech
Size
11-50 employees
Stage
Other
founded in
2015
Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
Something looks off?